Literature DB >> 26951659

Ablation of huntingtin in adult neurons is nondeleterious but its depletion in young mice causes acute pancreatitis.

Guohao Wang1, Xudong Liu1, Marta A Gaertig2, Shihua Li3, Xiao-Jiang Li4.   

Abstract

The Huntington's disease (HD) protein, huntingtin (HTT), is essential for early development. Because suppressing the expression of mutant HTT is an important approach to treat the disease, we must first understand the normal function of Htt in adults versus younger animals. Using inducible Htt knockout mice, we found that Htt depletion does not lead to adult neurodegeneration or animal death at >4 mo of age, which was also verified by selectively depleting Htt in neurons. On the other hand, young Htt KO mice die at 2 mo of age of acute pancreatitis due to the degeneration of pancreatic acinar cells. Importantly, Htt interacts with the trypsin inhibitor, serine protease inhibitor Kazal-type 3 (Spink3), to inhibit activation of digestive enzymes in acinar cells in young mice, and transgenic HTT can rescue the early death of Htt KO mice. These findings point out age- and cell type-dependent vital functions of Htt and the safety of knocking down neuronal Htt expression in adult brains as a treatment.

Entities:  

Keywords:  Huntingtin; acinus; aging; degeneration; pancreas

Mesh:

Substances:

Year:  2016        PMID: 26951659      PMCID: PMC4812735          DOI: 10.1073/pnas.1524575113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

1.  Enhanced trypsin activity in pancreatic acinar cells deficient for serine protease inhibitor kazal type 3.

Authors:  Masaki Ohmuraya; Masahiko Hirota; Kimi Araki; Hideo Baba; Ken-ichi Yamamura
Journal:  Pancreas       Date:  2006-07       Impact factor: 3.327

Review 2.  Huntington's disease: can mice lead the way to treatment?

Authors:  Zachary R Crook; David Housman
Journal:  Neuron       Date:  2011-02-10       Impact factor: 17.173

Review 3.  Gene therapy in mouse models of huntington disease.

Authors:  Amber L Southwell; Paul H Patterson
Journal:  Neuroscientist       Date:  2011-04       Impact factor: 7.519

4.  Contrasting gray and white matter changes in preclinical Huntington disease: an MRI study.

Authors:  D Stoffers; S Sheldon; J M Kuperman; J Goldstein; J Corey-Bloom; A R Aron
Journal:  Neurology       Date:  2010-04-13       Impact factor: 9.910

5.  Insufficiency of electrolyte and fluid secretion by pancreatic ductal cells leads to increased patient risk for pancreatitis.

Authors:  Péter Hegyi; Zoltán Rakonczay
Journal:  Am J Gastroenterol       Date:  2010-09       Impact factor: 10.864

Review 6.  Using non-coding small RNAs to develop therapies for Huntington's disease.

Authors:  Y Zhang; R M Friedlander
Journal:  Gene Ther       Date:  2011-12       Impact factor: 5.250

7.  Spatial and temporal requirements for huntingtin (Htt) in neuronal migration and survival during brain development.

Authors:  Yiai Tong; Thomas J Ha; Li Liu; Andrew Nishimoto; Anton Reiner; Dan Goldowitz
Journal:  J Neurosci       Date:  2011-10-12       Impact factor: 6.167

8.  Expression of Huntington's disease protein results in apoptotic neurons in the brains of cloned transgenic pigs.

Authors:  Dongshan Yang; Chuan-En Wang; Bentian Zhao; Wei Li; Zhen Ouyang; Zhaoming Liu; Huaqiang Yang; Pei Fan; Ashley O'Neill; Weiwang Gu; Hong Yi; Shihua Li; Liangxue Lai; Xiao-Jiang Li
Journal:  Hum Mol Genet       Date:  2010-07-21       Impact factor: 6.150

Review 9.  Role of genetic disorders in acute recurrent pancreatitis.

Authors:  Volker Keim
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

10.  Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.

Authors:  Michelle Gray; Dyna I Shirasaki; Carlos Cepeda; Véronique M André; Brian Wilburn; Xiao-Hong Lu; Jifang Tao; Irene Yamazaki; Shi-Hua Li; Yi E Sun; Xiao-Jiang Li; Michael S Levine; X William Yang
Journal:  J Neurosci       Date:  2008-06-11       Impact factor: 6.167

View more
  56 in total

Review 1.  Therapeutic approaches to Huntington disease: from the bench to the clinic.

Authors:  Nicholas S Caron; E Ray Dorsey; Michael R Hayden
Journal:  Nat Rev Drug Discov       Date:  2018-09-21       Impact factor: 84.694

2.  Artificial miRNAs Reduce Human Mutant Huntingtin Throughout the Striatum in a Transgenic Sheep Model of Huntington's Disease.

Authors:  Edith L Pfister; Natalie DiNardo; Erica Mondo; Florie Borel; Faith Conroy; Cara Fraser; Gwladys Gernoux; Xin Han; Danjing Hu; Emily Johnson; Lori Kennington; PengPeng Liu; Suzanne J Reid; Ellen Sapp; Petr Vodicka; Tim Kuchel; A Jennifer Morton; David Howland; Richard Moser; Miguel Sena-Esteves; Guangping Gao; Christian Mueller; Marian DiFiglia; Neil Aronin
Journal:  Hum Gene Ther       Date:  2018-02-23       Impact factor: 5.695

3.  CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington's disease.

Authors:  Su Yang; Renbao Chang; Huiming Yang; Ting Zhao; Yan Hong; Ha Eun Kong; Xiaobo Sun; Zhaohui Qin; Peng Jin; Shihua Li; Xiao-Jiang Li
Journal:  J Clin Invest       Date:  2017-06-19       Impact factor: 14.808

Review 4.  Therapeutic Update on Huntington's Disease: Symptomatic Treatments and Emerging Disease-Modifying Therapies.

Authors:  Deepa Dash; Tiago A Mestre
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

Review 5.  Neurodegenerative diseases: model organisms, pathology and autophagy.

Authors:  S N Suresh; Vijaya Verma; Shruthi Sateesh; James P Clement; Ravi Manjithaya
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

Review 6.  Translation of MicroRNA-Based Huntingtin-Lowering Therapies from Preclinical Studies to the Clinic.

Authors:  Jana Miniarikova; Melvin M Evers; Pavlina Konstantinova
Journal:  Mol Ther       Date:  2018-02-08       Impact factor: 11.454

Review 7.  A role for autophagy in Huntington's disease.

Authors:  Katherine R Croce; Ai Yamamoto
Journal:  Neurobiol Dis       Date:  2018-08-24       Impact factor: 5.996

8.  Postnatal and adult consequences of loss of huntingtin during development: Implications for Huntington's disease.

Authors:  Eduardo E Arteaga-Bracho; Maria Gulinello; Michael L Winchester; Nandini Pichamoorthy; Jenna R Petronglo; Alicia D Zambrano; Julio Inocencio; Chirstopher D De Jesus; Joseph O Louie; Solen Gokhan; Mark F Mehler; Aldrin E Molero
Journal:  Neurobiol Dis       Date:  2016-09-10       Impact factor: 5.996

9.  Striatal Projection Neurons Require Huntingtin for Synaptic Connectivity and Survival.

Authors:  Caley J Burrus; Spencer U McKinstry; Namsoo Kim; M Ilcim Ozlu; Aditya V Santoki; Francia Y Fang; Annie Ma; Yonca B Karadeniz; Atesh K Worthington; Ioannis Dragatsis; Scott Zeitlin; Henry H Yin; Cagla Eroglu
Journal:  Cell Rep       Date:  2020-01-21       Impact factor: 9.423

Review 10.  Modeling Polyglutamine Expansion Diseases with Induced Pluripotent Stem Cells.

Authors:  Swati Naphade; Kizito-Tshitoko Tshilenge; Lisa M Ellerby
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.